期刊文献+

产KPC型β-内酰胺酶肺炎克雷伯菌对氟喹诺酮类耐药机制研究 被引量:5

Investigation of fluoroquinolone-resistant mechanism of KPCβ-lactamase-producing Klebsiella pneumoniae isolates
原文传递
导出
摘要 目的探讨产KPC型β-内酰胺酶肺炎克雷伯菌对氟喹诺酮类药物的耐药机制,为指导临床合理使用抗菌药物提供依据。方法两所三甲综合性医院临床分离的23株产KPC型β-内酰胺酶肺炎克雷伯菌,采用K-B纸片法药敏试验,聚合酶链反应(PCR)方法对氟喹诺酮类药物作用靶位编码基因gyrA、parC和可移动遗传元件介导的aac(6′)-Ⅰb-cr、qnrA、qnrB、qnrS、qepA基因进行检测,对阳性产物进行测序,测序结果作BLAST对比分析。结果 23株产KPC型β-内酰胺酶肺炎克雷伯菌检出拓普异构酶ⅡA亚单位编码基因,gyrA喹诺酮耐药决定区(QRDR)的第83位密码子TCC→ATC有义突变(氨基酸序列S→I),第87位密码子GAC→GGC有义突变(氨基酸序列D→G),且23株菌株均出现拓普异构酶ⅣC亚单位编码基因parC喹诺酮耐药决定区(QRDR)第80位密码子AGC→ATC有义突变(氨基酸序列S→I);但23株产KPC型β-内酰胺酶肺炎克雷伯菌由可移动遗传元件可介导的氟喹诺酮类耐药相关基因(aac(6′)-Ⅰb-cr、qnrA、qnrB、qnrS、qepA)检测均为阴性。结论 23株产KPC型β-内酰胺酶肺炎克雷伯菌的gyrA与parC基因QRDR区的有义突变是氟喹诺酮类药物耐药的主要机制,加重了其耐药性,给临床抗菌药物选择带来困难,需引起重视。 OBJECTIVE To investigate the fluoroquinolne-resistant mechanism of KPC β-lactamase-producing Klebsiella pneumoniae isolates so as to guide the reasonable clinical use of antibiotics. METHODS Totally 23 strains of KPC β-1actamase-producing Klebsiella pneumoniae isolated from two three A hospitals were collected, then the drug susceptibility testing was performed, and the polymerase-chain-reaction (PCR) was used to detect fluoroquinolones target encoding genes such as gyrA and parC and the mobile genetic elements-mediated genes like aac(6')- I trcr, qnrA, qnrB, qnrS, and qepA, the positive PCR products were verified by DNA sequencing, and the results were compared and analyzed with BLAST searching. RESULTS The topoisomerase Ⅱ A subunit genes have been detected in all the 23 strains of KPC β-lactamase-producing Klebsiella pneumoniae, and the sense mutation of the 83th (amino acid sequence S→I) and 87th (amino acid sequence D→G) codon (TCC→ATC, GAC→GGC respectively) on quinolone-resistant determining region(QRDR) of gyrA occurred, and the 80th codon (AGC→ATC) ( amino acid sequence S→I)of topoisomerase IV C subunit genes parC occurred in all the 23 strains in every strains. Meanwhile, the detection of the fluoroquinolne-resistance-associated genes (aac (6')-I b-cr, qnrA, qnrB, qnrS, qepA) mediated by mobile genetic elements were all negative. CONCLUSION The fluoroquinolone-resistant mechanism of the 23 strains of KPC β-lactamase-producing Klebsiella pneumoniae is primarily attributed to the sense mutation occuring on QRDR of gyrA and parC, which aggregates the antimicrobial resistance and bring difficulties to the clinical use of antibiotics, it should be paid aattention to.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2013年第22期5388-5391,共4页 Chinese Journal of Nosocomiology
基金 江苏省“六大高峰人才”基金资助项目(WSN-206-123)
关键词 肺炎克雷伯菌 碳青霉烯酶 氟喹诺酮类 耐药 拓普异构酶 可移动遗传元件 Klebsiella pneumoniae Carbapenemases Fluoroquinolones Drug resistance Topoisomerase Mobilegenetic element
  • 相关文献

参考文献6

  • 1Weisenberg SA, Morgan DJ,Espinal'Witter R? et al. Clinicaloutcomes of patients with KPC-producing Klebsiella pneu-moniae following treatment with imipenem or meropenem[J].Diagn Microbiol Infect Dis,2009,64(2) :233-235.
  • 2Brisse S,Verhoef J. Phylogenetic diversity of Klebsiella pneumon-iae and Klebsiella oxytoca clinical isolates revealed by randomlyamplified polymorphic DNA, gyrA and parC genes sequencing andautomated ribotyping[J]. International journal of systematic andevolutionary microbiology,2001,51(3) :915-924.
  • 3Strahilevitz J, Jacoby GA,Hooper DC,et al. Plasmid-mediatedquinolone resistance: a multifaceted threat[J]. Clin MicrobiolRev,2009,22(4) :664-689.
  • 4Yamane K,Wachino JI,Suzuki Syetal. New Plasmid-MediatedFluoroquinolone Efflux Pump, QepA, Found in an Escherich-ia coli Clinical Isolate [J]. Antimicrob Agents Chemother,2007,51(9):3354-3360.
  • 5Robicsek Af Strahilevitz J,Jacobk GAfet al. Fluorpquinolone-modifying enzyme:a new adaptation of a common aminoglyco-side acetyltransferase [J]. nature medicine, 2006,12(1): 83-88.
  • 6Chen L,Mediavilla JR, Endimiani A, et al. Multiplex Real-Time PCR Assay for Detection and Classification of Klebsiellapneumoniae Carbapenemase Gene CblaKPC) Variants[J]. JClin Microbiol,2011,49(2) :579-585.

同被引文献49

  • 1尚芙蓉,蔡和伦.神经内科住院患者医院感染危险因素分析[J].湖北医药学院学报,2011,30(5):506-508. 被引量:17
  • 2高山,普珍,孙晓明,刘小康.肺炎克雷伯杆菌对氟喹诺酮类抗生素耐药机制的研究[J].华西药学杂志,2006,21(1):21-24. 被引量:13
  • 3刘秀卿,张镇松.妇科患者生殖道感染病原菌的分布及耐药性分析[J].河北医学,2007,13(2):206-209. 被引量:7
  • 4Li L, Wang B, Feng S, et al. Prevalence and characteristics of ex- tended - spectrum fl - lactamase and plasmld - mediated fluoro- quinolone resistance genes in Escherichia coli isolated from chickens in Anhui province, China[ J ]. PLoS One, 2014, 9 (8) : e104356.
  • 5Chen Y, Luo Y, Mao L, et al. A study on GvrA and ParC mu- tant in fluoroquinolone-rcsistant Kle/asiella prwumoraiae induced resistance strains in vitro[J]. Chin J Microeeol, 2009, 21 (2): 145-8.
  • 6Lau RW, Ho PL, Kao RY, et al. Molecular characterization of fluoroquinolone resistance in Mycobacteriurn tuberculosis: func- tional analysis of gyrA mutation at position 74[J]. Antimicrob A- gents Chemother, 2011, 55: 608-14.
  • 7Brisse S, Verhoe~ J. Phylogenetic diversity o[ Klebsiella pneu moniae and Klebsiella oxytoca clinical isolates revealed by ran domly amplified polymorphic DNA, gyrA and parC genes sequen eing and automated ribotypingl-J~. Int J Sys Evol Microbiol 2001, 51(3): 915-24.
  • 8Salgado CD, Ogragy N, Farr BM. Prevention and control of an timicrohial resistant infections in intensive care patients[J]. CritCare Med, 2005, 33(10): 2373-82.
  • 9Dettenkofer M, Ebner W, Els T, et al. Surveillance of nosoco mial infections in a neurology intensive care unitEJT. J Neurol 2001, 248(11) : 959-64.
  • 10Vargas M, Horcajada JP, Obach V, et al. Clinical consequences of infection in patients with acute strokeFJ~. Stroke, 2006, 37~ 461-5.

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部